Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of this study was to compare efficacy of high versus low doses of prednisone for induction of remission in autoimmune pancreatitis (AIP). METHODS: This is a retrospective, multicenter study including patients diagnosed with AIP between May 1992 and August 2011. Clinical, laboratory and imaging findings were assessed before treatment and at 1, 3, and 6 months after starting treatment. RESULTS: A total of 65 patients (57 males; median age, 63 years) were treated with an initial low dose (10-20 mg/d, n = 14), a medium dose (30 mg/d, n = 15), or a high dose (40-60 mg/d, n = 36) of prednisone. There were no significant differences in baseline characteristics between the treatment groups including age, presenting symptoms and laboratory results. During a follow-up period of 6 months, in nearly all patients, symptoms (jaundice, weight loss) resolved completely. After 6 months, treatment response with respect to symptomatic, radiological, and laboratory improvement was comparable for the different dosage groups. CONCLUSIONS: Response to therapy was comparable for AIP patients treated with doses of prednisone in the range of 10 to 60 mg/d. A prospective trial should be conducted to confirm efficacy of lower-dose prednisone treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“retrospective analyses from the Netherlands indicated that initial doses of 10-20 mg predniso(lo)ne daily may be as effective in controlling at least type 1 autoimmune pancreatitis and preventing disease relapse.280”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [280]
Citations
Cites
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Shimosegawa, T., Chari, S. T., Frulloni, L., Kamisawa, T., Kawa, S., Mino-Kenudson, M., Kim, M.-H., Klöppel, G., Lerch, M. M., Löhr, M., et al. (2011) · Pancreas · doi:10.1097/mpa.0b013e3182142fd2 · Cited by 1,526
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Standard steroid treatment for autoimmune pancreatitis
Kamisawa, T., Shimosegawa, T., Okazaki, K., Nishino, T., Watanabe, H., Kanno, A., Okumura, F., Nishikawa, T., Kobayashi, K., Ichiya, T., et al. (2009) · Gut · doi:10.1136/gut.2008.172908 · Cited by 724
Otsuki, M., Chung, J. B., Okazaki, K., Kim, M.-H., Kamisawa, T., Kawa, S., Park, S. W., Shimosegawa, T., Lee, K., Ito, T., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2205-6 · Cited by 425
Autoimmune related pancreatitis: Table 1
Okazaki, K., & Chiba, T. (2002) · Gut · doi:10.1136/gut.51.1.1 · Cited by 417
Glucocorticoids and the risk for initiation of hypoglycemic therapy
Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314
Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment
Hirano, K., Tada, M., Isayama, H., Yagioka, H., Sasaki, T., Kogure, H., Nakai, Y., Sasahira, N., Tsujino, T., Yoshida, H., et al. (2007) · Gut · doi:10.1136/gut.2006.115246 · Cited by 283
Working members of Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society, Kamisawa, T., Okazaki, K., Kawa, S., Shimosegawa, T., & Tanaka, M. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0221-9 · Cited by 260
Sclerosing pancreato-cholangitis responsive to steroid therapy
Erkelens, G., Vleggaar, F., Lesterhuis, W., van Buuren, H., & van der Werf, S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00603-0 · Cited by 239
Self-citation
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Self-citationRecent Advances in Autoimmune Pancreatitis
Hart, P. A., Zen, Y., & Chari, S. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.010 · Cited by 400
Advances in the diagnosis and management of IgG4 related disease
Lanzillotta, M., Mancuso, G., & Della-Torre, E. (2020) · BMJ · doi:10.1136/bmj.m1067 · Cited by 360
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations
Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620934911 · Cited by 252
Self-citationInternational consensus for the treatment of autoimmune pancreatitis
Okazaki, K., Chari, S. T., Frulloni, L., Lerch, M. M., Kamisawa, T., Kawa, S., Kim, M.-H., Lévy, P., Masamune, A., Webster, G., et al. (2017) · Pancreatology · doi:10.1016/j.pan.2016.12.003 · Cited by 249
Metadata
- Authors
- Buijs, J., van Heerde, M. J., Rauws, E. A. J., de Buy Wenniger, L. J. M., Hansen, B. E., Biermann, K., Verheij, J., Vleggaar, F. P., Brink, M. A., Beuers, U. H. W., Kuipers, E. J., Bruno, M. J., & van Buuren, H. R.
- Affiliations
- Erasmus MC (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Meander Medisch Centrum (NL)
- University Medical Center Utrecht (NL)
- Corresponding author
- Buijs, Jorie
- Hansen, Bettina E.
- Kuipers, Ernst J.
- Bruno, Marco J.
- ORCID
- Venue
- Pancreas
- Published
- 2014-03
- Volume
- 43
- Issue
- 2
- Pages
- 261-267
- ISSN
- 0885-3177 (ISSN-L)
- OpenAlex
- W2008022161
- Cited by
- 51
- References
- 24
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 1
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Pancreas (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Keywords
- autoimmune pancreatitis, prednisone, induction therapy, corticosteroid dose, low-dose prednisone, remission induction, treatment response, jaundice, weight loss
- MeSH terms
- Adult, Aged, Autoimmune Diseases, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glucocorticoids, Humans, Jaundice, Male, Middle Aged, Pancreatitis, Prednisone, Retrospective Studies, Time Factors, Weight Loss, Treatment Outcome, Induction Chemotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis. https://app.cochat.ai/papers/10.1097/mpa.0000000000000044
- The paper
- Buijs, J., van Heerde, M. J., Rauws, E. A. J., de Buy Wenniger, L. J. M., Hansen, B. E., Biermann, K., Verheij, J., Vleggaar, F. P., Brink, M. A., Beuers, U. H. W., Kuipers, E. J., Bruno, M. J., & van Buuren, H. R. (2014). Comparable Efficacy of Low- Versus High-Dose Induction Corticosteroid Treatment in Autoimmune Pancreatitis. Pancreas. https://doi.org/10.1097/mpa.0000000000000044
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.